UNSPSC 51391714: Dimetofrine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H17NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BOM1J10QQM, chemically known as 4-hydroxy-3,5-dimethoxy-alpha-((methylamino)methyl)benzyl alcohol but generally known as dimetofrine, which bears US NIH Compound Identifier 31513. European Medicines Agency schedules Dimetofrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07181MIG.

UNSPSC 51391714 Dimetofrine is a Commodity code that covers pharmaceutical products and related medical supplies, though recent state and local activity under this code shows minimal alignment with the nominal drug category. State and local governments soliciting under this code are purchasing naloxone (opioid reversal medication) and drug deactivation systems to support community health and public safety initiatives. Issuing bodies include county health departments and state health agencies executing purchases through competitive bidding processes and exploratory procurement vehicles. The work involves sourcing finished pharmaceutical products and ancillary medical equipment for distribution to health facilities and community programs, with vendors responsible for delivery, compliance with drug-free workplace and E-Verify requirements, and adherence to applicable federal environmental regulations when FEMA funding is involved.

Seminole County, Florida posted an IFB (Solicitation IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, and the Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription fulfillment and cost management strategies outside traditional pharmacy benefit manager and group purchasing organization channels. Geographic activity spans Florida and Texas, with Texas activity focused on longer-term program design rather than immediate product procurement. Recent opportunities show state and local governments addressing opioid mitigation and pharmaceutical access through both spot-market purchasing and strategic vendor capability assessments; no recent opportunities under this code show activity outside the health and human services context.